ConductScience.org, home

Library / Genes

H4C6: H4 clustered histone 6

1 protein, 408 patents, 0 drugs, 0 trials, 4,137 NIH grants and 6,586 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolH4C6HGNC
NameH4 clustered histone 6HGNC
NCBI Gene ID8361NCBI Gene
HGNC IDHGNC:4783HGNC
EnsemblENSG00000274618NCBI Gene
AliasesH4, H4/c, H4FC, HIST1H4FNCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P62805Histone H4103633Ensembl, GeneID, HGNCUniProt

Patents 408

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1449206P62805Espacenet
JP 2026004568 A2026-01-1449207P62805Espacenet
JP 2026004568 A2026-01-1449208P62805Espacenet
JP 2026004568 A2026-01-1449209P62805Espacenet
JP 2026004568 A2026-01-1449210P62805Espacenet
JP 2026004568 A2026-01-1449211P62805Espacenet
JP 2026004568 A2026-01-1449213P62805Espacenet
JP 2026004568 A2026-01-1449214P62805Espacenet
JP 2026004568 A2026-01-1449215P62805Espacenet
JP 2026004568 A2026-01-1449216P62805Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 4137

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA008748Cancer Center Support Grant322,025NIH's project files
P30CA016672Cancer Center Support Grant232,025NIH's project files
R01AI118891Viral modulation of epitranscriptomic mechanisms212,025NIH's project files
P30CA010815Consolidated Basic Cancer Research Program152,025NIH's project files
R01CA132878Post-translational Modifications in DNA Damage Response: a Structural Perspective142,025NIH's project files
P30CA016520Abramson Cancer Center Support Grant132,025NIH's project files
P30CA046934University of Colorado Cancer Center Support Grant132,025NIH's project files
P30CA016087Cancer Center Support Grant122,025NIH's project files
P30CA016058Cancer Center Support Grant112,025NIH's project files
P30CA016086Cancer Center Support Grant102,025NIH's project files

Papers 6586

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42802180PubTator, text miningPubMed
42797967PubTator, text miningPubMed
42789058PubTator, text miningPubMed
42703165PubTator, text miningPubMed
42627024PubTator, text miningPubMed
42615495PubTator, text miningPubMed
42585950PubTator, text miningPubMed
42561958PubTator, text miningPubMed
42543258PubTator, text miningPubMed
42498174PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license